These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23349910)

  • 1. Sulodexide decreases albuminuria and regulates matrix protein accumulation in C57BL/6 mice with streptozotocin-induced type I diabetic nephropathy.
    Yung S; Chau MK; Zhang Q; Zhang CZ; Chan TM
    PLoS One; 2013; 8(1):e54501. PubMed ID: 23349910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulodexide ameliorates early but not late kidney disease in models of radiation nephropathy and diabetic nephropathy.
    Rossini M; Naito T; Yang H; Freeman M; Donnert E; Ma LJ; Dunn SR; Sharma K; Fogo AB
    Nephrol Dial Transplant; 2010 Jun; 25(6):1803-10. PubMed ID: 20061322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
    Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
    Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating fibronectin contributes to mesangial expansion in a murine model of type 1 diabetes.
    Klemis V; Ghura H; Federico G; Würfel C; Bentmann A; Gretz N; Miyazaki T; Gröne HJ; Nakchbandi IA
    Kidney Int; 2017 Jun; 91(6):1374-1385. PubMed ID: 28159318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
    Wang D; Zhang G; Chen X; Wei T; Liu C; Chen C; Gong Y; Wei Q
    Int J Mol Med; 2018 May; 41(5):2784-2792. PubMed ID: 29484381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine ameliorates renal injury by regulating G proteins-AC- cAMP signaling in diabetic rats with nephropathy.
    Tang LQ; Wang FL; Zhu LN; Lv F; Liu S; Zhang ST
    Mol Biol Rep; 2013 Jun; 40(6):3913-23. PubMed ID: 23266672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.
    Koya D; Haneda M; Nakagawa H; Isshiki K; Sato H; Maeda S; Sugimoto T; Yasuda H; Kashiwagi A; Ways DK; King GL; Kikkawa R
    FASEB J; 2000 Mar; 14(3):439-47. PubMed ID: 10698958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
    Mizuno S; Nakamura T
    Am J Physiol Renal Physiol; 2004 Jan; 286(1):F134-43. PubMed ID: 14519594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AS101 prevents diabetic nephropathy progression and mesangial cell dysfunction: regulation of the AKT downstream pathway.
    Shemesh II; Rozen-Zvi B; Kalechman Y; Gafter U; Sredni B
    PLoS One; 2014; 9(12):e114287. PubMed ID: 25474550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PKC-beta1 mediates glucose-induced Akt activation and TGF-beta1 upregulation in mesangial cells.
    Wu D; Peng F; Zhang B; Ingram AJ; Kelly DJ; Gilbert RE; Gao B; Krepinsky JC
    J Am Soc Nephrol; 2009 Mar; 20(3):554-66. PubMed ID: 19211711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.
    Meier M; Park JK; Overheu D; Kirsch T; Lindschau C; Gueler F; Leitges M; Menne J; Haller H
    Diabetes; 2007 Feb; 56(2):346-54. PubMed ID: 17259378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purple corn anthocyanins retard diabetes-associated glomerulosclerosis in mesangial cells and db/db mice.
    Li J; Kang MK; Kim JK; Kim JL; Kang SW; Lim SS; Kang YH
    Eur J Nutr; 2012 Dec; 51(8):961-73. PubMed ID: 22102159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.
    Zhang MH; Feng L; Zhu MM; Gu JF; Jiang J; Cheng XD; Ding SM; Wu C; Jia XB
    J Ethnopharmacol; 2014; 151(1):591-600. PubMed ID: 24269777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bradykinin inhibits high glucose- and growth factor-induced collagen synthesis in mesangial cells through the B2-kinin receptor.
    Blaes N; Pécher C; Mehrenberger M; Cellier E; Praddaude F; Chevalier J; Tack I; Couture R; Girolami JP
    Am J Physiol Renal Physiol; 2012 Jul; 303(2):F293-303. PubMed ID: 22573379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Src kinase blocks high glucose-induced EGFR transactivation and collagen synthesis in mesangial cells and prevents diabetic nephropathy in mice.
    Taniguchi K; Xia L; Goldberg HJ; Lee KW; Shah A; Stavar L; Masson EA; Momen A; Shikatani EA; John R; Husain M; Fantus IG
    Diabetes; 2013 Nov; 62(11):3874-86. PubMed ID: 23942551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sestrin2 attenuates renal damage by regulating Hippo pathway in diabetic nephropathy.
    Bian Y; Shi C; Song S; Mu L; Wu M; Qiu D; Dong J; Zhang W; Yuan C; Wang D; Zhou Z; Dong X; Shi Y
    Cell Tissue Res; 2022 Oct; 390(1):93-112. PubMed ID: 35821438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role for osteopontin in diabetic nephropathy.
    Nicholas SB; Liu J; Kim J; Ren Y; Collins AR; Nguyen L; Hsueh WA
    Kidney Int; 2010 Apr; 77(7):588-600. PubMed ID: 20130530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered DNA methylation of TRIM13 in diabetic nephropathy suppresses mesangial collagen synthesis by promoting ubiquitination of CHOP.
    Li Y; Ren D; Shen Y; Zheng X; Xu G
    EBioMedicine; 2020 Jan; 51():102582. PubMed ID: 31901873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy.
    Shahni R; Gnudi L; King A; Jones P; Malik AN
    Diabetologia; 2012 Mar; 55(3):825-34. PubMed ID: 22095236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.